Osteoporosis in Men:
An Endocrine Society Clinical Practice Guideline
The Endocrine Society’s
Clinical Guidelines S;? ?
w w w . m e d l i v e . c n
Authors: Nelson B. Watts, Robert A. Adler, John P. Bilezikian, Matthew T. Drake, Richard Eastell, Eric S. Orwoll,
and Joel S. Finkelstein
Affiliations: Mercy Health Osteoporosis & Bone Health Services (N.B.W.), Cincinnati Ohio 45236; McGuire
Veterans Affairs Medical Center and Virginia Commonwealth University School of Medicine (R.A.A.), Richmond,
Virginia 23298; Columbia University College of Physicians and Surgeons (J.P.B.), New York, New York 10032;
College of Medicine, Mayo Clinic (M.T.D.), Rochester, Minnesota 55905; Medical School at the University of
Sheffield (R.E.), Sheffield S10 2RX, United Kingdom; Oregon Health & Sciences University (E.S.O.), Portland,
Oregon
97239; and Massachusetts General Hospital, Harvard Medical
School (J.S.F.), Boston, Massachusetts 02114
Co-Sponsoring Associations: American Society for Bone and Mineral Research (ASBMR), European Calcified
Tissue Society (ECTS), European Society of Endocrinology (ESE), International Society for Clinical Densitometry
(ISCD)
Disclaimer: Clinical Practice Guidelines are developed to be of assistance to endocrinologists and other health
care professionals by
providing guidance and recommendations for particular areas of practice. The Guidelines
should not be considered inclusive of all proper approaches or methods, or exclusive of others. The Guidelines
cannot guarantee any specific outcome, nor do they establish a standard of care. The Guidelines are not intended
to dictate the treatment of a particular patient. Treatment decisions must be made based on the independent
judgment of health care providers and each patient’s individual circumstances.
The
Endocrine Society makes no warranty, express or implied, regarding the Guidelines and specifically
excludes any warranties of merchantability and fitness for a particular use or
2012ENDO+男性骨质疏松临床指南.pdf